GSK126,
GSK126,
1346574-57-9,
GSK-126,
EZH2 inhibitor,
GSK 126,
UNII-W4OGW9QZ97,
W4OGW9QZ97,
CHEMBL3287735,
(S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,
1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indole-4-carboxamide,
FKSFKBQGSFSOSM-QFIPXVFZSA-N,
A9G,
MLS006010251,
GTPL7012,
SCHEMBL12180401,
AOB1764,
EX-A499,
SYN5012,
CHEBI:124921,
BCP06129,
GSK2816126A,
KS-00000XH6,
BDBM50017293,
GSK-2816126A,
s7061,
ZINC72318146,
AKOS027322309,
CS-1401,
GSK2816126,
QC-9703,
GSK-2816126,
NCGC00347286-01,
AS-16379,
BC600501,
HY-13470,
SC-94427,
SMR004701327,
AB0032512,
FT-0700443,
X5824,
W-6022,
EZH2 inhibitor;GSK-126;GSK 126;GSK2816126A;GSK-2816126A;GSK 2816126A,
(S)-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide,
1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide,
1H-Indole-4-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-,
N-((1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-1H-indole-4-carboxamide,
N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide,
D07TNE,
C31H38N6O2,
A3446,
A11757,
C577920,
(S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide(GSK126),